The Purpura Treatment Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. The growth of this market is underpinned by several factors, including the increasing prevalence of purpura-related conditions, advancements in treatment methodologies, and a growing awareness of available therapies. The rising number of patients...